Welcome to your Weekly Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
Hoth Therapeutics, Inc, a biopharmaceutical company focused on creating new treatments, has submitted a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) as
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, has shared encouraging results from several preclinical studies on its precision antisense drug candidate HT-KIT. The findings show
Protection through 2039, ensuring long-term commercial exclusivity Hoth Therapeutics, a clinical-stage biopharmaceutical company developing innovative therapies, announced that they have obtained Japan Country Patent No.
Reports 50% Reduction in Pruritus (Mean Score Dropped from 1.6 to 0.8) by Day 21 inOpen-Label Portion of CLEER HT-001 Phase 2a clinical Trial for
Hoth Therapeutics, a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, announced its collaboration with OnTargetx R&D Inc. to advance research for its cancer-fighting
